Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 21: 1414-1415, 1975;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalofoutis, A.
Right arrow Articles by Miras, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalofoutis, A.
Right arrow Articles by Miras, C.

Clinical Chemistry, Vol 21, 1414-1415, Copyright © 1975 by the American Association for Clinical Chemistry

Erythrocyte 2,3-Diphosphoglycerate as Related to Diabetes and Obesity

Anastasios Kalofoutis 1, Gérard Jullien 1, Antonios Koutselinis 1, and Constantinos Miras 1

1 Department of Biological Chemistry, University of Athens School of Medicine, Goudi, Athens 609, Greece.

2,3-Diphosphoglycerate was determined in the erythrocytes of 17 diabetic and 18 obese patients. Results for obese subjects were significantly (P < .01) different from those obtained for 21 healthy subjects. Results for obese and diabetic patients also differed significantly (P < .01), but not those for diabetic and healthy subjects. Hemoglobin, hematocrit, or bicarbonate measurements did not differ among the three groups.

Submitted on April 7, 1975
Accepted on May 23, 1975






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American Association for Clinical Chemistry.